|
New #1
Indiana’s pride and joy, Eli Lilly, is now the most valuable drug company in America. They edged out Johnson & Johnson for the top spot on the back of monster sales of Mounjaro and its potential as a weight loss drug down the line.
Hey, if you find yourself in Indianapolis, you can walk around Eli Lilly’s former house at Newfields and think about if he were alive today, that house would be about 20 times bigger.
Revivicor
The company who makes gene-edited pig kidneys with the hopes of getting them approved for human transplantation brought out the big PR guns yesterday with two simultaneous releases of case studies in which brain-dead patients had their kidneys replaced with the gene-edited pig variety.
In a seven-day case, the patient received pig kidneys, each with 10 modified genes, which ended up producing urine within four minutes and a total of 37 L in the first day. Whoa. Slow down, kidneys.
Slow down they did - urine production was down to about 5 L per day by the 7th day.
In the second, longer case, the patient's kidney has lasted 32 days, this time with only a single gene modification to the organ.
We are one step closer to kidney vending machines.
Solar System
Last week we demonstrated how far our Biopharm Universe had fallen. So, here's some better news - the solar system is healthy.
Starting at Blue Earth Diagnostics we pass MoonLake Immunotherapeutics and then encounter Venus MedTech, followed by the Mercurys (Bio, Biomed, Medical).
Continuing past Sun Pharmaceuticals we eventually reach Jupiter Neurosciences with its moons Ganymede & Io Biotech before grazing Saturn's moon Titan Pharmaceuticals.
As we pass into the abyss, Pluto Biosciences appears in front of us, letting us know all that's left beyond it is Voyager Therapeutics.
Foghorn Therapeutics
Sent out a press release to let the world know they hired a new CMO. What a snoozer.
You know, maybe it would have been a lot cooler if they had announced this using another method of communication like, oh we don’t know, a FOGHORN.
Impilo
New company launched this week and they’re calling themselves Impilo Therapeutics. This begs the question – did they check the BPG defunct page, see a company called Impilo Therapeutics was acquired in 2020 and still pick that name? Or did they simply ignore the most comprehensive resource of dead biotech company names?
Ohhhh wait a minute, wait a minute, wait a minute. The CEO of the company that acquired Impilo was David Slack. The new CEO of this Impilo is David Slack. Here's the history:
-Impilo Therapeutics was acquired by CEND Therapeutics in 2020
-CEND Therapeutics merged with Caladrius Biosciences in Apr 2022, to become Lisata Therapeutics
-Lisata Therapeutics spun out some tech into the new Impilo Theraputics.
The circle of biotech!
The question is, do we create a new entry for this reincarnation of Impilo, or assign it to the original entry. Decisions, decisions...
Name Fail: AgNovos Bioscience
Just learned about this company and almost skipped right over it because we don't list agricultural biotech companies. A company putting Ag before an upper-case letter always means they do agricultural stuff. Until today.
We wish them the best of luck in treating bone disease, despite the plant-centric name.
| 
